Research
- Research
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHB Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
How the Future of GLP-1 Affordability Depends on Competition
July 29, 2026
By Amanda Frost, PhD Vice President, Research, PCMA There is no shortage of opinions these days about GLP-1 prescription drugs:...
From Flashy Ads to Expensive Drugs: 5 Things You Need to Know About Misleading Drug Advertisements
July 27, 2026
By Amanda Frost, PhD Vice President, Research, PCMA I don’t watch much television these days, but when I do, I can be assured of...
What Would You Do to Protect $50 Billion a Year?
July 22, 2026
By Amanda Frost, PhD Vice President, Research, PCMA Did you know: the original patent for semaglutide – better known as...
